Skip to main content
Watch Insiders
OTLK filings

Corporate insider profile

Yezan Munther Haddadin Filing Activity

Latest reported as Corporate insider of Outlook Therapeutics, Inc. (OTLK).

Purchase filings
2
Reported companies
1
Net open-market value
$39,105
Latest transaction
Jun 2, 2026

Affiliated corporations

Reported company relationships

OTLKLatest reported

Outlook Therapeutics, Inc.

Corporate insider

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 2, 2026Outlook Therapeutics, Inc. (OTLK)Corporate insiderOpen Market Purchase29,000$0.83$24,145
May 26, 2026Outlook Therapeutics, Inc. (OTLK)Corporate insiderOpen Market Purchase34,000$0.44$14,960